(1)
Dewiputri, S.; Sidik, M. Clinical Outcome of Intravenous Glucocorticoid and Rituximab in Moderate to Severe Thyroid Eye Disease. OI 2017, 42 (2). https://doi.org/10.35749/journal.v42i2.82.